NEUROEPIGENIX, LLC

Biotech · Private

Epigenetic enzyme inhibitor small molecule for reducing stress- and dependence-related alcohol drinking in Alcohol Use Disorder

Grants
$393K
1 award
Sector median: 1
Raised
—
No Form D on record
Contracts
—
No federal contracts on record
Patents
—
No published records under this name
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Federal grantDepartment of Health and Human Services · Phase I · Development of novel pharmacotherapies for AUD$392,942
Federal grant · SBIR/STTR

Peer position

Biotech · 4373 companies · ranked on federal contract value
Biotech companies ranked by federal contract value
#CompanyContractsDisclosed equity
1267MARTINGALE LABS, INC.——
1268Monte Rosa Therapeutics, Inc.—$143M
1269Tyra Biosciences, Inc.—$200M
1270NEUROEPIGENIX, LLC——
1271Third Harmonic Bio——
1272BridgeBio Oncology Therapeutics——
1273Beam Therapeutics—$180M

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.